“In vivo” biological standardization of the allergenic extracts Dermatophagoides pteronyssinus (DPT) and Dermatophagoides farinae (DF) in patients sensitized to them.

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-525628-13-00

Enrollment

Registered

2026-06-26

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DPT and DF., IgE-mediated respiratory allergic disease due to the allergen whose extract is to be standardized

Brief summary

In vivo determination of the biological activity of the allergenic extracts DPT and DF

Detailed description

In vitro biological standardization of DPT and DF allergenic extracts

Interventions

DRUGSolución para prueba con extractos alergénicos DPT 0.1 por punción cutánea

DRUGSolución para prueba con extractos alergénicos DF 0.1 por punción cutánea

DRUGSolución para prueba con extractos alergénicos DPT 10 por punción cutánea

DRUGHISTAMINE DIHYDROCHLORIDE

DRUGSolución para prueba con extractos alergénicos DF 10 por punción cutánea

DRUGSolución para prueba con extractos alergénicos DPT 0.01 por punción cutánea

DRUGSolución para prueba con extractos alergénicos DPT 1 por punción cutánea

DRUGSolución para prueba con extractos alergénicos DF 0.01 por punción cutánea

DRUGSolución para prueba con extractos alergénicos DF 1 por punción cutánea

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
In vivo determination of the biological activity of the allergenic extracts DPT and DF	—

Secondary

Measure	Time frame
In vitro biological standardization of DPT and DF allergenic extracts	—

Outcome results

None listed

Source: EU CTIS · Data processed: Jun 27, 2026